跳至主要内容
临床试验/CTRI/2025/02/081167
CTRI/2025/02/081167尚未招募不适用

Comparative study of uranium nitricum 30 versus individualized homoeopathic medicine in management of type 2DM

Dr Kavya Singh1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年3月6日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To compare the changes in random blood glucose level before and after treatment in patients with type 2 diabetes mellitus at baseline and after 6 months of treatment to compare effectiveness of uranium nitricum 30 and individualized homoeopathic medicine.

研究概览

简要总结

Diabetes is a chronic condition where the body struggles with insulin production or its effectiveness, leading to high blood glucose levels, which can damage vital systems like nerves and blood vessels. Type 2 diabetes (T2DM) is particularly prevalent, affecting millions globally, with India being the second-largest affected country. In 2019, diabetes caused 1.5 million deaths, and its prevalence is expected to rise further. While conventional treatments like oral antidiabetic drugs (OAD) and insulin offer some relief, many patients fail to achieve optimal results, prompting interest in alternative treatments, such as homeopathy.

This study aims to compare the effectiveness of individualized homeopathic treatment and Uranium Nitricum 30 in managing T2DM. The primary objective is to evaluate which treatment better reduces fasting blood glucose levels and alleviates diabetes symptoms using the Diabetes Symptom Checklist. Homeopathic treatments, particularly individualized remedies, have shown promise in managing T2DM, with some studies suggesting benefits for specific remedies like Uranium Nitricum 30.

The study will be conducted over a period of 18 months, involving 60 patients diagnosed with T2DM. Patients will be randomly assigned to receive either individualized homeopathic treatment or Uranium Nitricum 30. Their blood glucose levels and symptoms will be regularly monitored to assess the effectiveness of the treatments.

The study will provide valuable insights into the potential of homeopathy as an alternative treatment for managing type 2 diabetes, especially in populations with limited access to conventional therapies.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients suffering from Type 2 DM (Hb A1c- 6.5% or higher) at the time of screening.
  • Patients with random blood glucose 200 mg/dl and above.
  • Patients of age group 30-70 years.
  • Patients of both sexes and all religions.
  • Patients who are previously diagnosed with Type 2 Diabetes Mellitus and are taking Oral Anti Glycemic Drugs.
  • Patient who gives their valid consent to participate in the study.

排除标准

  • Patients suffering from Type 2 DM (Hb A1c --more than 10%) at the time of screening.
  • Patients with secondary complications of diabetes like nephropathy and retinopathy.
  • Patients who are taking insulin injections.
  • Patient unwilling to participate in the study.
  • Pregnant women and lactating mothers.

结局指标

主要结局

To compare the changes in random blood glucose level before and after treatment in patients with type 2 diabetes mellitus at baseline and after 6 months of treatment to compare effectiveness of uranium nitricum 30 and individualized homoeopathic medicine.

时间窗: 12weeks,24weeks

次要结局

  • To compare changes in DSC-R (Diabetes Symptom Checklist-Revised) at baseline and every 3 months of treatment.(12weeks ,24 weeks)

研究者

发起方
Dr Kavya Singh
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Kavya Singh

State National Homoeopathic Medical College and Hospital, Lucknow

研究点 (1)

Loading locations...

相似试验